MDGL logo

Madrigal Pharmaceuticals (MDGL) Accounts payable

annual accounts payable:

$43.60M+$15.56M(+55.48%)
December 31, 2024

Summary

  • As of today (June 2, 2025), MDGL annual accounts payable is $43.60 million, with the most recent change of +$15.56 million (+55.48%) on December 31, 2024.
  • During the last 3 years, MDGL annual accounts payable has risen by +$22.22 million (+103.92%).
  • MDGL annual accounts payable is now at all-time high.

Performance

MDGL Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLbalance sheet metrics

quarterly accounts payable:

$42.06M-$1.54M(-3.54%)
March 31, 2025

Summary

  • As of today (June 2, 2025), MDGL quarterly accounts payable is $42.06 million, with the most recent change of -$1.54 million (-3.54%) on March 31, 2025.
  • Over the past year, MDGL quarterly accounts payable has increased by +$20.53 million (+95.35%).
  • MDGL quarterly accounts payable is now -8.51% below its all-time high of $45.97 million, reached on September 30, 2024.

Performance

MDGL quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

MDGL Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+55.5%+95.3%
3 y3 years+103.9%+84.6%
5 y5 years+3601.1%+3671.8%

MDGL Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+103.9%-8.5%+367.6%
5 y5-yearat high+4187.0%-8.5%+4035.3%
alltimeall timeat high>+9999.0%-8.5%>+9999.0%

MDGL Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$42.06M(-3.5%)
Dec 2024
$43.60M(+55.5%)
$43.60M(-5.1%)
Sep 2024
-
$45.97M(+411.1%)
Jun 2024
-
$8.99M(-58.2%)
Mar 2024
-
$21.53M(-23.2%)
Dec 2023
$28.04M(+17.7%)
$28.04M(+69.5%)
Sep 2023
-
$16.54M(-5.7%)
Jun 2023
-
$17.53M(+44.6%)
Mar 2023
-
$12.13M(-49.1%)
Dec 2022
$23.83M(+11.5%)
$23.83M(+28.4%)
Sep 2022
-
$18.56M(+64.4%)
Jun 2022
-
$11.29M(-50.4%)
Mar 2022
-
$22.78M(+6.5%)
Dec 2021
$21.38M(+2002.3%)
$21.38M(+105.2%)
Sep 2021
-
$10.42M(+876.4%)
Jun 2021
-
$1.07M(-75.7%)
Mar 2021
-
$4.40M(+332.3%)
Dec 2020
$1.02M(-13.7%)
$1.02M(-83.8%)
Sep 2020
-
$6.28M(+25.4%)
Jun 2020
-
$5.00M(+348.8%)
Mar 2020
-
$1.11M(-5.3%)
Dec 2019
$1.18M(-52.6%)
$1.18M(+52.4%)
Sep 2019
-
$773.00K(+73.3%)
Jun 2019
-
$446.00K(-89.8%)
Mar 2019
-
$4.38M(+76.0%)
Dec 2018
$2.49M(+28.9%)
$2.49M(+141.2%)
Sep 2018
-
$1.03M(+75.3%)
Jun 2018
-
$588.00K(-58.6%)
Mar 2018
-
$1.42M(-26.4%)
Dec 2017
$1.93M(+153.1%)
$1.93M(+37.8%)
Sep 2017
-
$1.40M(+8.9%)
Jun 2017
-
$1.28M(-53.8%)
Mar 2017
-
$2.78M(+264.8%)
Dec 2016
$762.00K(+644.9%)
$762.00K(-34.3%)
Sep 2016
-
$1.16M(+70.6%)
Jun 2016
-
$680.00K(-8.6%)
Mar 2016
-
$744.00K(+627.3%)
Dec 2015
$102.30K
$102.30K(-92.8%)
Sep 2015
-
$1.42M(-52.8%)
DateAnnualQuarterly
Jun 2015
-
$3.02M(-19.3%)
Mar 2015
-
$3.74M(+19.1%)
Dec 2014
$3.14M(-52.4%)
$3.14M(-29.3%)
Sep 2014
-
$4.44M(-15.0%)
Jun 2014
-
$5.23M(-10.1%)
Mar 2014
-
$5.81M(-11.8%)
Dec 2013
$6.59M(+16.4%)
$6.59M(+15.7%)
Sep 2013
-
$5.69M(+9.0%)
Jun 2013
-
$5.22M(-8.7%)
Mar 2013
-
$5.72M(+1.0%)
Dec 2012
$5.66M(+63.3%)
$5.66M(+53.4%)
Sep 2012
-
$3.69M(+6.4%)
Jun 2012
-
$3.47M(+14.1%)
Mar 2012
-
$3.04M(-12.3%)
Dec 2011
$3.47M(+80.1%)
$3.47M(+18.7%)
Sep 2011
-
$2.92M(+46.1%)
Jun 2011
-
$2.00M(+18.2%)
Mar 2011
-
$1.69M(-12.2%)
Dec 2010
$1.93M(-51.4%)
$1.93M(-19.6%)
Sep 2010
-
$2.39M(+87.0%)
Jun 2010
-
$1.28M(-12.4%)
Mar 2010
-
$1.46M(-63.1%)
Dec 2009
$3.96M(+18.8%)
$3.96M(-12.8%)
Sep 2009
-
$4.54M(-24.3%)
Jun 2009
-
$6.00M(-43.5%)
Mar 2009
-
$10.62M(+218.7%)
Dec 2008
$3.33M(+33.9%)
$3.33M(+66.6%)
Sep 2008
-
$2.00M(+35.9%)
Jun 2008
-
$1.47M(-67.5%)
Mar 2008
-
$4.53M(+82.1%)
Dec 2007
$2.49M(-5.5%)
$2.49M(+26.3%)
Sep 2007
-
$1.97M(-0.6%)
Jun 2007
-
$1.98M(+8.7%)
Mar 2007
-
$1.82M(-30.8%)
Dec 2006
$2.63M(-21.7%)
$2.63M(+48.1%)
Sep 2006
-
$1.78M(-47.1%)
Dec 2005
$3.36M(+16.5%)
$3.36M(-17.2%)
Mar 2005
-
$4.06M
Dec 2004
$2.88M(+1280.4%)
-
Dec 2003
$209.00K
-

FAQ

  • What is Madrigal Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals annual accounts payable year-on-year change?
  • What is Madrigal Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Madrigal Pharmaceuticals?
  • What is Madrigal Pharmaceuticals quarterly accounts payable year-on-year change?

What is Madrigal Pharmaceuticals annual accounts payable?

The current annual accounts payable of MDGL is $43.60M

What is the all time high annual accounts payable for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high annual accounts payable is $43.60M

What is Madrigal Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, MDGL annual accounts payable has changed by +$15.56M (+55.48%)

What is Madrigal Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of MDGL is $42.06M

What is the all time high quarterly accounts payable for Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals all-time high quarterly accounts payable is $45.97M

What is Madrigal Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, MDGL quarterly accounts payable has changed by +$20.53M (+95.35%)
On this page